Optic Atrophy

2

Review clinical trials related to Optic Atrophy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Stem Cell Ophthalmology Treatment Study II

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: MD Stem CellsUpdated: Jun 29, 2026Locations: 4
Eligibility criteria

Have objective, documented damage to the retina or optic nerve unlikely to impro... [+7]

Patients who are not capable of an adequate ophthalmologic examination or evalua... [+3]

Status: Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy

Participants needed: 20
Trial details
Phase: Phase 1Biological sex: AllType: InterventionalSponsor: The Foundation for Orthopaedics and Regenerative MedicineUpdated: Apr 17, 2025Locations: 2
Eligibility criteria

Diagnosis of NAION (non-arteritic ischemic optic neuropathy) [+1]

Active infection [+9]